Breast cancer

Showing 9 of 0 results

• Personalized acquired CDK4/6i resistance: Associations with baseline characteristics like obesity in real-world clinical-multiomics data

  SABCS

  • Breast cancer
• Real-world glucagon-like peptide-1 use and association with clinical characteristics, social determinants, and circulating tumor DNA positivity in patients with breast cancer

  SABCS

  • Publication summary
  • Publications
  • Breast cancer
• Racial/ethnic inequities in access to novel therapies and outcomes in triple negative breast cancer

  SABCS

  • Publication summary
  • Publications
  • Health equity
  • Breast cancer
• Real-world overall survival with palbociclib plus an aromatase inhibitor in patients with HR+/HER2− metastatic breast cancer who are overweight/obese

  SABCS

  • Publication summary
  • Publications
  • Metastatic breast cancer
  • Breast cancer
• Real-world treatment patterns in 1954 US patients with HER2-negative early breast cancer and germline BRCA mutations (2021–2025)

  SABCS

  • Publication summary
  • Publications
  • Treatment patterns
  • Breast cancer
• Behind the Research: An Exploration of Real-World Data's Ability to Support Adverse Event Surveillance at ISPOR Europe
  • Real-world evidence
  • Machine learning
  • Breast cancer
  • Regulatory
  • Post marketing requirements
• Incidence of neutropenia adverse events identified in electronic health care records among initiators of CDK4/6 inhibitors with advanced breast cancer in the UK

  ISPOR Europe

  • Publication summary
  • Publications
  • Breast cancer
• Real-world study of breast cancer epidemiology and treatment patterns: A pilot study to assess EHR-derived data in the United Kingdom

  ISPOR Europe

  • Publication summary
  • Publications
  • Breast cancer
• Laboratory testing patterns in patients with breast cancer treated With CDK4/6 Inhibitors: A multi-country electronic health record study from the UK, Germany, and Japan

  ISPOR Europe

  • Publication summary
  • Publications
  • Breast cancer